1180 Bull. Chem. Soc. Jpn. Vol. 82, No. 9 (2009)
Synthesis of 2-(Substituted Amino)pyrimidines
1542, 1484, 1362, 1024, 832 cm¹1; 1H NMR (CDCl3, 500 MHz): ¤
7.34 (d, 2H, J = 6.9 Hz), 7.31 (t, 2H, J = 7.4 Hz), 7.25 (m, 1H),
6.33 (s, 1H), 5.25 (br s, 1H), 4.65 (d, 2H, J = 5.9 Hz), 2.28 (s, 6H);
13C NMR (CDCl3, 125 MHz): ¤c 167.9, 162.7, 140.1, 128.9, 127.9,
127.4, 110.3, 45.8, 24.3; HRMS (ES+): Calcd for C13H16N3
(M + H+): 214.1344. Found: 214.1339.
2H), 0.86 (t, 3H, J = 7.28 Hz); 13C NMR (CDCl3, 125 MHz): ¤c
165.9, 154.9, 124.6, 78.4, 40.7, 31.8, 20.4, 14.1; HRMS (ES+):
Calcd for C8H15N4O (M + H+) 183.1242. Found: 183.1418.
2-Butylaminopyrimidine-4,6-diol (8l): Yield: 25%; Rf (4%
MeOH/CHCl3) = 0.43; Mp 76-78 °C; IR: 3420, 3181, 2929,
1709, 1626, 1526, 1250, 837 cm¹1; 1H NMR (CDCl3, 400 MHz): ¤
5.19 (s, 1H), 5.10 (s, 1H), 4.97 (s, 1H), 3.48 (s, 1H), 3.28 (m, 2H),
1.50 (m, 2H), 1.34 (m, 2H), 1.26 (t, 3H, J = 7.28 Hz); 13C NMR
(CDCl3, 75 MHz): ¤c 169.2, 167.7, 166.0, 40.4, 29.6, 19.9, 13.7;
MS (FIA): m/z (%): 182.0 [(M ¹ H)+, 5], 208.0 [(M + 2H +
Na)+, 50]; HRMS (ES+): Found: 182.1368 (M ¹ H)+.
2-Butylamino-6-methyl-3H-pyrimidin-4-one (8e):
Yield:
68%; Off-white solid; Rf (25% ethyl acetate/petroleum ether) =
0.40; Mp 68-70 °C (lit.19 91 °C); IR: 3255, 2958, 2872, 1656,
1
1608, 1518, 1451, 1331, 1220, 967 cm¹1; H NMR (CDCl3, 400
MHz): ¤ 11.70 (br s, 1H), 5.89 (br s, 1H), 5.57 (s, 1H), 3.37 (m,
2H), 2.16 (s, 3H), 1.57 (m, 2H), 1.37 (m, 2H), 0.94 (t, 3H, J = 7.4
Hz); 13C NMR (CDCl3, 125 MHz): ¤c 164.2, 163.1, 154.7, 108.2,
102.7, 41.7, 31.8, 20.4, 14.1; HRMS (ES+): Calcd for C9H16N3O
(M + H+): 182.1250. Found: 182.1283.
4,6-Dimethyl-2-(1-phenylethylamino)pyrimidine
(8m):
Yield: 75%; Rf (10% ethyl acetate/petroleum ether) = 0.43;
25
Liquid; ½¡ꢀD +95.4 (c 0.074, CHCl3); IR: 3425, 2975, 2930,
1644, 1567, 1367, 1224 cm¹1, 1H NMR (CDCl3, 500 MHz): ¤ 7.49
(d, 2H, J = 7.0 Hz), 7.40 (t, 2H, J = 7.6 Hz), 7.31 (t, 1H, J = 7.3
Hz), 6.37 (s, 1H), 5.35 (br s, 1H), 5.32 (m, 1H), 2.34 (s, 6H), 1.63
(d, 3H, J = 6.6 Hz); 13C NMR (CDCl3, 125 MHz): ¤c 167.8, 161.9,
145.3, 128.8, 127.2, 126.6, 110.2, 50.6, 24.3, 23.3; HRMS (ES+):
Calcd for C14H18N3 (M + H+): 228.1500. Found: 228.1489.
2-(4-Methoxyanilino)-4,6-dimethylpyrimidine (8f): Yield:
67%; Rf (15% ethyl acetate/petroleum ether) = 0.45; Mp 80-82 °C
(lit.19 88-89 °C); IR: 3260, 2933, 1588, 1562, 1508, 1458, 1339,
1
1034, 826 cm¹1; H NMR (CDCl3, 500 MHz): ¤ 7.55 (d, 2H, J =
6.8 Hz), 6.93 (br s, 1H), 6.87 (d, 2H, J = 9.0 Hz), 6.44 (s, 1H), 3.79
(s, 3H), 2.34 (s, 6H); 13C NMR (CDCl3, 75 MHz): ¤c 167.4, 159.9,
154.9, 133.1, 120.9, 113.9, 110.9, 55.4, 23.7; HRMS (ES+): Calcd
for C13H16N3O (M + H+): 230.1293. Found: 230.1302.
4,6-Diphenyl-2-(1-phenylethylamino)pyrimidine
(8n):
Yield: 69%; Rf (8% ethyl acetate/petroleum ether) = 0.43; Mp
25
74-76 °C; ½¡ꢀD +46.58 (c 0.068, CHCl3); IR: 3066, 2919, 2849,
2-Butylamino-4-methyl-6-phenylpyrimidine (8g):
Yield:
1568, 1543, 1491, 1214, 1028; 1H NMR (CDCl3, 500 MHz): ¤
8.02 (m, 5H), 7.49 (m, 7H), 7.39 (s, 1H), 7.34 (t, 2H, J = 6.8 Hz),
7.23 (m, 1H), 5.58 (d, 1H, J = 7.1 Hz), 5.37 (m, 1H), 1.67 (d, 3H,
J = 6.9 Hz); 13C NMR (CDCl3, 125 MHz): ¤c 166.1, 162.5, 145.6,
138.4, 130.7, 129.1, 128.9, 127.5, 127.3, 126.6, 103.5, 51.5, 23.4;
HRMS (ESI-TOF): Calcd for C24H22N3 (M + H+): 352.1808.
Found: 352.1813.
75%; Rf (15% ethyl acetate/petroleum ether) = 0.45; Mp 55-
56 °C; IR: 3278, 2926, 2856, 1557, 1462, 1376, 1230, 1028,
1
822 cm¹1; H NMR (CDCl3, 500 MHz): ¤ 8.02 (m, 2H), 7.45 (m,
3H), 6.85 (s, 1H), 5.06 (br s, 1H), 3.52 (q, 2H, J = 12.9 Hz), 2.39
(s, 3H), 1.63 (m, 2H), 1.45 (m, 2H), 0.97 (t, 3H, J = 7.4 Hz);
13C NMR (CDCl3, 75 MHz): ¤c 168.2, 164.5, 162.7, 137.8, 130.1,
128.5, 126.9, 105.8, 41.1, 31.9, 24.2, 20.1, 13.8; HRMS (ES+):
Calcd for C15H20N3 (M + H+): 242.1641. Found: 242.1653.
2-Benzylamino-6-methyl-3H-pyrimidin-4-one (8h): Yield:
2-Furfurylamino-4-methyl-6-phenylpyrimidine (8o): Yield:
70%; Rf (6% ethyl acetate/petroleum ether) = 0.39; Mp 120-
¹1
122 °C; IR: 3247, 3066, 2926, 1600, 1555, 1439, 1069 cm
;
65%; Rf (25% ethyl acetate/petroleum ether) = 0.43; Mp 62-
1H NMR (CDCl3, 400 MHz): ¤ 8.02 (s, 2H), 7.44 (m, 3H), 7.35 (s,
1H), 6.90 (s, 1H), 6.30 (s, 1H), 6.26 (s, 1H), 5.38 (br s, 1H), 4.73
(d, 2H, J = 5.7 Hz), 2.39 (s, 3H); 13C NMR (CDCl3, 125 MHz):
¤c 168.9, 164.8, 162.6, 151.3, 142.9, 130.7, 129.0, 128.6, 127.4,
110.8, 107.8, 107.1, 40.6, 24.7; HRMS (ES+): Calcd for
C16H16N3O (M + H+) 266.1287. Found: 266.1255 (M + H+).
4,6-Dimethyl-2-(6-methyl-2-pyridylamino)pyrimidine (8p):
Yield: 55%; Rf (20% ethyl acetate/petroleum ether) = 0.42; Mp
¹1
63 °C; IR: 3279, 3030, 2925, 1656, 1602, 1515, 1326, 967 cm
;
1H NMR (CDCl3, 400 MHz): ¤ 11.52 (br s, 1H), 7.33 (m, 5H), 6.62
(s, 1H), 5.31 (s, 1H), 4.56 (s, 2H), 2.11 (s, 3H); 13C NMR (CDCl3,
75 MHz): ¤c 164.3, 153.9, 138.1, 129.3, 128.5, 127.3, 126.5,
100.5, 44.8, 23.5; HRMS (ES+): Calcd for C12H14N3O (M + H+):
216.1094. Found: 216.1134.
2-Butylamino-4,6-diphenylpyrimidine (8i): Yield: 72%; Rf
(12% ethyl acetate/petroleum ether) = 0.45; Mp 65-66 °C; IR:
88-90 °C; IR: 3245, 2927, 2885, 2410, 1623, 1595, 1250, 827
1
¹1
3248, 2968, 2846, 1558, 1548, 1480, 1208, 856 cm¹1; H NMR
cm ;
1H NMR (CDCl3, 500 MHz): ¤ 8.28 (d, 1H, J = 8.3 Hz),
(CDCl3, 500 MHz): ¤ 8.09 (d, 4H, J = 5.1 Hz), 7.49 (m, 6H),
7.39 (s, 1H), 5.26 (t, 1H, J = 5.3 Hz), 3.59 (q, 2H, J = 13.3 Hz),
1.67 (m, 2H), 1.48 (m, 2H), 0.98 (t, 3H, J = 7.1 Hz); 13C NMR
(CDCl3, 125 MHz): ¤c 166.1, 163.6, 138.6, 130.7, 129.1, 127.5,
103.1, 41.8, 32.4, 20.7, 14.4; HRMS (ES+): Calcd for C20H22N3
(M + H+): 304.1813. Found: 304.1807.
7.80 (br s, 1H), 7.55 (t, 1H, J = 7.9 Hz), 6.76 (d, 1H, J = 7.4 Hz),
6.53 (s, 1H), 2.44 (s, 3H), 2.38 (s, 6H); 13C NMR (CDCl3,
125 MHz): ¤c 167.4, 158.9, 156.6, 152.4, 137.9, 116.6, 112.2,
109.2, 24.1, 23.9; HRMS (ES+): Calcd for C12H15N4 (M + H+):
215.1328. Found: 215.1293.
N-(2,6-Dimethylpyrimidin-4-yl)-N¤-(4,6-dimethylpyrimidin-
6-Amino-2-benzylamino-3H-pyrimidin-4-one (8j):
Yield:
2-yl)-1,6-hexanediamine (9q):
Yield: 64%; Rf (10% ethyl
56%; Rf (3% MeOH/CHCl3) = 0.44; Mp 116-118 °C; IR: 3330,
acetate/petroleum ether) = 0.42; Mp 122-124 °C (lit19 135 °C);
1
¹1
2926, 1614, 1467, 1275, 1104, 792 cm¹1; H NMR (CDCl3, 400
IR: 3270, 2925, 2854, 1599, 1574, 1468, 1357, 1142 cm ;
MHz): ¤ 12.70 (br s, 1H), 7.24 (m, 5H), 6.66 (br s, 1H), 4.59 (s,
1H), 4.52 (s, 2H), 4.49 (d, 2H, J = 5.3 Hz); 13C NMR (CDCl3,
125 MHz): ¤c 165.8, 154.8, 138.9, 128.9, 127.9, 127.6, 124.0,
78.6, 44.7; HRMS (ESI-TOF): Calcd for C11H13N4O (M + H+),
217.1084. Found: 217.1160.
1H NMR (CDCl3, 500 MHz): ¤ 6.28 (s, 2H), 4.94 (br s, 2H),
3.39 (q, 4H, J = 13.4 Hz), 2.27 (s, 12H), 1.58 (m, 4H), 1.43 (m,
4H); 13C NMR (CDCl3, 75 MHz): ¤c 167.2, 162.3, 109.3, 41.2,
29.6, 26.5, 23.7; HRMS (ES+): Calcd for C18H29N6 (M + H+):
329.2422. Found: 329.2441.
6-Amino-2-butylamino-3H-pyrimidin-4-one (8k):
Yield:
Compound 9r: Yield: 60%; Rf (8% ethyl acetate/petroleum
58%; Rf (3% MeOH/CHCl3) = 0.43; Mp 146-148 °C; IR: 3340,
ether) = 0.44; Mp 162-164 °C; IR: 3264, 2928, 2824, 1636, 1565,
¹1
¹1
2931, 1615, 1478, 1428, 1281 cm
;
1H NMR (DMSO-d6 in
1468, 1332, 832 cm ;
1H NMR (CDCl3, 500 MHz): ¤ 7.34 (s,
CDCl3, 400 MHz): ¤ 10.03 (br s, 1H), 5.66 (br s, 1H), 4.76 (s, 1H),
4.49 (br s, 2H), 3.22 (q, 2H, J = 12.3 Hz), 1.46 (m, 2H), 1.31 (m,
1H), 7.25 (s, 1H), 7.24 (s, 2H), 6.32 (s, 2H), 5.26 (br s, 2H), 4.63
(d, 4H, J = 5.9 Hz), 2.28 (s, 12H); 13C NMR (CDCl3, 125 MHz):